Showing results 594 to 613 of 639
< previous
next >
| Issue Date | Title | Author(s) |
| 2023 | T cell expressed microRNA-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1 | Tang, William W.; Ekiz, H. Atakan ; Voth, Warren P.; Bauer, Kaylyn M.; Barba, Cindy; Ghazaryan, Arevik; Nelson, Morgan |
| Jan-2016 | T cells in tumor microenvironment | Kiraz, Yağmur ; Baran, Yusuf ; Nalbant, Ayten |
| 2009 | Targeting ceramide metabolism increased sensitivity of Philadelphia positif chronic megacaryoblastic leukemia cells to dasatinib | Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
| Mar-2015 | Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line | Tüfekçi, Özlem; Kartal Yandım, Melis; Ören, Hale; İrken, Gülersu; Baran, Yusuf |
| Oct-2011 | Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation | Baran, Yusuf ; Bielawski, Jacek; Gündüz, Ufuk; Öğretmen, Besim |
| 2014 | Targeting sphingosine kinase-1/spingosine-1-phosphate receptor 2 signalling pathway to overcome T315I mutation in 32DCL3 cells | Adan Gökbulut, Aysun ; Öğretmen, Besim; Baran, Yusuf |
| Oct-2010 | Therapeutic applications of bioactive sphingolipids in hematological malignancies | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| Jan-2017 | Therapeutic effects of AICAR and DOX conjugated multifunctional nanoparticles in sensitization and elimination of cancer cells via survivin targeting | Dağlıoğlu, Cenk ; Okutucu, Burcu |
| May-2014 | Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells | Solmaz, Soner; Adan Gökbulut, Aysun ; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Boğa, Can; Çakmakoğlu, Bedia; Kozanoğlu, İlknur; Baran, Yusuf |
| 2015 | Therapeutic potential of fisetin and identification of its mechanisms in action in chronic myeloid leukemia and acute promyelocytic leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2014 | Therapeutic potential of fisetin, vitexin and hesperetin on chronic myeloid leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2023 | Therapeutic potential of luteolin on cancer | Çetinkaya, Melisa; Baran, Yusuf |
| Jan-2013 | Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer | Kartal Yandım, Melis; Apohan, Elif; Baran, Yusuf |
| 2010 | Therapeutic potential of targeting sphingolipid signaling pathways in various types of cancers | Baran, Yusuf ; Başsoy, Esen Yonca; Çakır, Zeynep; Camgöz, Aylin; Gencer, Emel Başak; Kartal, Melis; Can, Geylani; Ekiz, Hüseyin Atakan ; Güçlüler, Gözde |
| 2015 | Therapeutic potentials of fisetin, hesperetin and vitexin on chronic myeloid leukemia and acute myeloid leukemia cells | Adan Gökbulut, Aysun |
| 2020 | Therapeutic Potentials of Inhibition of Jumonji C Domain-containing Demethylases in Acute Myeloid Leukemia | Koca, Duygu; Hastar, Nurcan; Engür, Selin; Kiraz, Yağmur ; Ulu, Gizem Tuğçe ; Çekdemir, Demet; Baran, Yusuf |
| Nov-2014 | Thiol peroxidase deficiency leads to increased mutational load and decreased fitness in saccharomyces cerevisiae | Kaya, Alaattin; Lobanov, Alexey V.; Gerashchenko, Maxim V.; Koren, Amnon; Fomenko, Dmitri E.; Koç, Ahmet ; Gladyshev, Vadim N. |
| Jun-2006 | Thioredoxin is required for deoxyribonucleotide pool maintenance during S phase | Koç, Ahmet ; Mathews, Christopher K.; Wheeler, Linda J.; Gross, Michael K.; Merrill, Gary Frederic |
| 2014 | Three dimensional microfluidic device that determines metastatic capacity and homing choices | Pesen Okvur, Devrim |
| 2010 | Thrips parazitoiti Ceranisus (Hymenoptera: Eulophidae) cinsinin morfolojik yapı ve 28S D2 rDNA temelinde Türkiye’deki güncel taksonomik durumları | Doğanlar, Oğuzhan; Doğanlar, Mikdat; Frary, Anne |
